by admin | Aug 21, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By The National Cancer Institute – In November 2023, the Food and Drug Administration announced that it was investigating more than 20 instances of second cancers—specifically, T-cell lymphomas—in people who had been treated with CAR T-cell therapies. In several...
by admin | Aug 20, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Technology Networks – Research offers new hope for treating neurodevelopmental disorders by activating dormant neural stem cells. Scientists from Duke-NUS Medical School and the Mechanobiology Institute (MBI) at the National University of Singapore (NUS) have...
by admin | Aug 19, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By University of Louisville School of Medicine – A new stem cell therapy for heart failure is being tested in patients at the University of Louisville and UofL Health. The trial is the first in the U.S. to test umbilical cord-derived stem cells in patients for...
by admin | Aug 16, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Natalie Healey – Nature Medicine Going from the laboratory to an approved therapy in 11 years is no mean feat. That is the story of the world’s first approved CRISPR–Cas9 therapy, greenlit by the US Food and Drug Administration in December 2023. Casgevy...
by admin | Aug 15, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Inside Precision Medicine – The immunotherapy afamitresgene autoleucel (afami-cel) for the treatment of adults with the rare soft tissue cancer called synovial sarcoma was granted accelerated approval late last week by the U.S. Food and Drug Administration...
